Business & Industry
CDSCO to Introduce Integrated Drug Regulatory Platform in 18 Months
The Central Drugs Standard Control Organisation (CDSCO) has announced plans to launch the first phase of a comprehensive end-to-end digital drug regulatory platform within the next 18 months. Designed as a single-window interface for the Indian pharmaceutical industry, the...
News
Resilience and Eli Lilly Expand Strategic Partnership with $750 Million Ohio Manufacturing Investment
Resilience has announced an expansion of its strategic partnership with Eli Lilly to boost domestic medicine production across the United States. The Cincinnati-based contract development and manufacturing organization and the pharmaceutical giant, which first established their collaboration in 2023,...
Business & Industry
WHO Introduces Global Regulatory Framework for Decarbonizing Pharmaceuticals
The World Health Organization (WHO) has officially launched the first global framework intended to assist medicines regulators in advancing the development of greener pharmaceuticals while maintaining the highest standards of safety, quality, and efficacy. The document, titled "Towards a...
News
Why Operational Resilience is Becoming A Strategic Priority Across Pharmaceutical Facilities
Every aspect of business continues to evolve as the need to meet operational resilience requirements becomes a greater priority. That can be within businesses moving on from aging business continuity plans in the face of changing markets and operating...
News
TRT Safety: What Current Research Actually Says About Long-Term Use
Testosterone replacement therapy has spent years caught between two extreme narratives.
One side presents TRT as inherently dangerous, with unavoidable risks to the heart, prostate, and overall health. The other treats it like a harmless upgrade that almost any man...
Business & Industry
Merck Signs Voluntary Licensing Deals for Oral HIV Pill
Merck has entered into seven voluntary licensing agreements with generic manufacturers to produce and distribute lower-cost versions of alimatravir, its experimental once-monthly oral HIV pill. The royalty-free agreements will cover both public and private sectors across 129 low- and...
Business & Industry
Trump Proposes Generic Drug Tariffs to Drive Reshoring Effort
President Donald Trump announced plans to implement massive generic drug tariffs starting at 100% in August 2028, scaling up to 200% in August 2029, in an effort to incentivize the pharmaceutical industry to move production to the United States.
The...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
